| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Urokinase-type plasminogen activator |
|---|
| Ligand | BDBM50109378 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_212981 |
|---|
| Ki | 138±n/a nM |
|---|
| Citation |  Rudolph, MJ; Illig, CR; Subasinghe, NL; Wilson, KJ; Hoffman, JB; Randle, T; Green, D; Molloy, CJ; Soll, RM; Lewandowski, F; Zhang, M; Bone, R; Spurlino, JC; Deckman, IC; Manthey, C; Sharp, C; Maguire, D; Grasberger, BL; DesJarlais, RL; Zhou, Z Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitors. Bioorg Med Chem Lett12:491-5 (2002) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Urokinase-type plasminogen activator |
|---|
| Name: | Urokinase-type plasminogen activator |
|---|
| Synonyms: | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator/surface receptor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 48528.62 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P00749 |
|---|
| Residue: | 431 |
|---|
| Sequence: | MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQ
HCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHN
YCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKII
GGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLG
RSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICL
PSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKML
CAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR
SHTKEENGLAL
|
|
|
|---|
| BDBM50109378 |
|---|
| n/a |
|---|
| Name | BDBM50109378 |
|---|
| Synonyms: | 5-Ethyl-4-(4-phenyl-thiazol-2-yl)-thiophene-2-carboxamidine | CHEMBL441273 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H15N3S2 |
|---|
| Mol. Mass. | 313.44 |
|---|
| SMILES | CCc1sc(cc1-c1nc(cs1)-c1ccccc1)C(N)=N |
|---|
| Structure | 
|
|---|
Search and Browse
